Applying state-of-the-art technologies, we try to understand diseases in an to date unconceivable accurateness to offer our patients a therapy tailored to their specific need.
The platform focuses on the further development and translation of “personalized medicine” which now plays an important role in all areas of basic medical research as well as in medical care. The Tübingen Center for Academic Drug Discovery (TüCADD) has established itself in the field of drug development. The translation of personalized medicine approaches into patient-centered care is implemented by the Center for Personalized Medicine (ZPM) based at the University Hospital of Tübingen. The drug candidates identified at the newly founded M3 Research Center - targeting individual combinations of characteristics in the metabolome and microbiome - can be quickly brought into clinical trials through the platform network.
Spokesperson of the platform
Prof. Dr. Nisar P. Malek
Medical Director of Internal Medicine I, Medical Clinic of the University Hospital Tübingen
Prof. Dr. Stefan Laufer
Pharmaceutical Chemistry, Pharmaceutical Institute, Eberhard Karls University of Tübingen
Plattform coordination
Dr. Yvonne Möller
University Hospital Tübingen, M3 Research Center, Otfried-Müller-Straße 37, 72076 Tübingen, Germany
E-Mail
tel:+4970712985320
